Latest Breaking News On - Lotus pharmaceuticals - Page 1 : vimarsana.com

NRx Pharmaceuticals, Inc (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript

NRx Pharmaceuticals, Inc (NASDAQ:NRXP) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaFrance generalJonathan javittDennis mcbrideRichard naridoMatthew duffyMichael manyakFondation fondamentalDan javittAndrew nierenbergStephen willardTim mooreNephron pharmaceuticalsHead of bipolar research at harvard massOffice of undersecretary defense

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

United statesNews networkAlvogen pharmaceuticalsTherapeutics incNeurorx incNephron pharmaceuticals of west columbiaNorthwestern universityNrx pharmaceuticals incUs department of defenseNephron pharmaceuticalsAlvogen incLotus pharmaceuticals incUs national institutes of healthBreakthrough therapyNew drug applicationFast track designation

NRx Pharma Achieves Data-lock In Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study

Biopharmaceutical company NRx Pharmaceuticals, Inc. (NRXP) announced Monday that it has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101.

Alvogen incLotus pharmaceuticals incNrx pharmaceuticals incTreatment resistant bipolar depression studyLotus pharmaceuticalsBreakthrough therapy designationFast track designationBiomarker letterSpecial protocol agreementSuicidal treatment resistant bipolar

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan javittAndrew nierenbergNrx pharmaceuticalsAlvogen incNrx pharmaceuticals incNrxp nrx pharmaceuticalsLotus pharmaceuticals incTreatment resistant bipolar depression studyLotus pharmaceuticalsBreakthrough therapy designationFast track designationBiomarker letterSpecial protocol agreementSuicidal treatment resistant bipolarSevere bipolar depression

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update

NRx Pharmaceuticals (NRXP) Reports Q4, Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMarion leboyerStephen willardMichael grunebaumMocrane abbarJanet rehnquistSecurities exchangeLotus pharmaceuticals incPrnewswire nrx pharmaceuticals incAlvogen incExchange commissionTherapeutics incNephron pharmaceuticals incCompany board of directorsCompany scientific leadership sappko